References
- Lukács J, Schliemann S, Elsner P. Lichen planus and lichenoid reactions as a systemic disease. Clin Dermatol 2015;33:512–519
- Breathnach S. Drug reactions. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook’s textbook of dermatology. Vol. 4. 8th ed. Oxford: Blackwell Science; 2010:73.1–177
- Baibergenova A, Donovan J. Lichen planopilaris: update on pathogenesis and treatment. Skinmed 2013;11:161–165
- Ismail SB, Kumar SK, Zain RB. Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci 2007;49:89–106
- Payette MJ, Weston G, Humphrey S, et al Lichen planus and other lichenoid dermatoses: kids are not just little people. Clin Dermatol 2015;33:631–643
- Ma Y, Chen X, Guan S. Terbinafine: novel formulations that potentiate antifungal activities. Drugs Today 2015;51:197–208
- Bayata S, Ermertcan AT, Ates M, Temiz P. Acute generalized exanthematous pustulosis in a child probably induced by terbinafine. Indian J Dermatol Venereol Leprol 2015;81:95
- Champagne C, Ratnavel R, Wong T. Severe Rowell syndrome associated with oral terbinafine. Clin Exp Dermatol 2012;37:822–823
- Ozturk G, Turk BG, Karaca N, et al Generalized pustular eruptions due to terbinafine. Cutan Ocul Toxicol 2012;31:81–84
- Coquart N, Kupfer-Bessaguet I, Staroz F, Plantin P. Acute generalized exanthematous pustulosis (AGEP) induced by terbinafine and two different antibiotics: four recurrences. Eur J Dermatol 2010;20:638–639
- Ibrahimi OA, Gunawardane N, Sepehr A, Reynolds RV. Terbinafine-induced acute generalized exanthematous pustulosis (AGEP) responsive to high dose intravenous corticosteroid. Dermatol Online J 2009;15:8
- Tokuyama Y, Senoh A, Setsu N, Iwatsuki K. Pustular psoriasis induced by terbinafine: differential diagnosis from acute generalized exanthematous pustulosis. Eur J Dermatol 2008;18:725–726
- Mancano MA. Patient with terbinafine-induced subacute cutaneous lupus erythematosus followed by thalidomide-induced orofacial neuropathy; beta blocker use, hypertension, and the risk of psoriasis; eczematous reaction to intravenous immunoglobulin; nicolau syndrome after intra-articular glucocorticoid injection; troponin leak associated with drug-induced methemoglobinemia. Hosp Pharm 2015;50:13–17